Company
Guangzhou Wondfo Biotech Co.,Ltd
Headquarters: Guangzhou, China
Employees: 2,926
Market Cap
CN¥11.81 Billion
CNY as of July 1, 2023
US$1.63 Billion
Guangzhou Wondfo Biotech Co.,Ltd Categories
China
languages
Healthcare
languages
Diagnostics & Research
China Healthcare
China Diagnostics & Research
Top Competitors by Market Capitalization
Industry: Diagnostics & Research
| Company | Market Cap (USD) |
|---|---|
Thermo Fisher Scientific
|
$199.03 B |
|
Danaher
|
$175.38 B |
Siemens Healthineers AG
|
$62.71 B |
|
DexCom, Inc.
|
$49.13 B |
Lonza Group Ltd
|
$43.73 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
|
UnitedHealth Group
|
$428.70 B |
|
Lilly
|
$417.05 B |
|
Johnson & Johnson
|
$412.24 B |
Novo Nordisk
|
$329.83 B |
|
Merck
|
$275.82 B |
Detailed Description
Guangzhou Wondfo Biotech Co.,Ltd, a biological company, engages in the research and development, production, and sale of point-of-care testing products, and rapid diagnosis and chronic disease management solutions. The company offers rapid test kits for COVID-19, drug of abuse, tumor, infectious, fertility, and sexually transmitted diseases, as well as immunofluorescence devices to detect cardiovascular diseases, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and other diseases. It also provides blood gas, optical coagulation, and dry chemistry analyzers. The company was founded in 1992 and is headquartered in Guangzhou, China.
Unlock the Power of Financial AI:
Try Disfold AI Free for 7 Days!
Stocks & Indices
Guangzhou Wondfo Biotech Co.,Ltd has the following listings and related stock indices.
Stock: SZSE: 300482 wb_incandescent